Abstract
Omeprazole is a potent new peptic-acid—secretion inhibitor that acts by inhibiting membrane H+/K+-transporting ATPase1; its mechanism is therefore different from that of H2 antagonists, such as ranitidine and cimetidine, which are known —particularly the latter2 — to provoke gynecomastia.